Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 to 75

FES-Cycling With Blood Flow Restriction for SCI/D Patients

Official title: Assessing the Safety and Feasibility of Functional Electrical Stimulation Cycling Coupled With Blood Flow Restriction in a Spinal Cord Injury Population

Run by Toronto Rehabilitation Institute · NCT07588503 · Data updated 2026-11-12

This study tests safe and feasible use of functional electrical stimulation cycling with blood flow restriction in adults with spinal cord injury to see if it can help reduce cardiometabolic risk.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment6 (estimated)
SponsorToronto Rehabilitation Institute
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJune 15, 2026
Main results expectedJanuary 1, 2027
Study endsSeptember 30, 2027
Registry record updatedMay 14, 2026
Trial IDNCT07588503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–75 with chronic SCI (C5–T10), AIS A–D, at least 1 year post-injury, and multiple cardiometabolic risk factors.

Probably not a fit

Individuals without cardiometabolic risk factors or those with the listed exclusion conditions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1 trial evaluates the safety and practicality of combining FES-Cycling with blood flow restriction in people with spinal cord injury. Eligible adults with chronic SCI (C5–T10) and multiple cardiometabolic risk factors will participate in a structured, moderate-intensity aerobic program using FES-assisted cycling while cuffs modestly restrict blood flow. Researchers will monitor safety, tolerability, and feasibility, including adverse events and adherence, to inform future efficacy studies. The study builds on preliminary data suggesting BFR can enhance muscle burden and metabolic responses in SCI/D patients. The trial is conducted at the Lyndhurst Centre in Toronto, led by Dr. B. Catharine Craven, with CAN-TAP-TALENT collaboration.

Why it matters

Potential benefit: If successful, participants may experience improved cardiometabolic risk factors and better engagement in aerobic exercise.

How similar studies have gone: Prior small studies suggest BFR with exercise is feasible in SCI/D, but this project uniquely tests moderate-intensity BFR-augmented FES cycling.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult (≥ 18 to ≤ 75yrs)
* Male or female
* Chronic Injury (\>1yr)
* Diagnosis of SCI at levels between C5 to T10 (AIS A-D) with traumatic or non-traumatic etiology.
* ≥3 Cardiometabolic risk parameters

Exclusion Criteria:

* A prior or current history of venous thromboembolism
* Pressure injury of the pelvis, mid to upper thigh region, or foot
* Managing a lower limb fracture
* Any history of embolic stroke
* Myocardial infarction
* Current untreated hypertension
* Language, psychiatric, cognitive, or communicative disability (e.g., traumatic brain injury) that compromises the participant's autonomy to voluntarily join the study, follow its instructions and/or operate the device.
* Current alcohol or street drug use disorder.
* Current use of an anticoagulant medication.
* Frequent episodes of autonomic dysreflexia unresponsive to therapy (e.g., 3-5 times a week).
* Unresolved deep vein thromboembolism (VTE) in the past six months.
* Severe spasticity preventing the necessary range of motion for cycling.
* Active implantable medical device (e.g., pacemaker, ITB pump).
* Inability to provide informed consent.
* Severe active concurrent medical conditions (e.g., skin or respiratory infections, lung, pressure sores).
* Unstable spine or unhealed limbs or pelvic fractures.
* Active heterotopic ossification interfering with the lower extremity range of motion.

Where it's running

  • Lyndhurst Centre
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.